Opportunistic Infections: Clinical Trials

33 trials for Opportunistic Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 3 recruiting, 2 active not recruiting, 1 not yet recruiting. 33 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 233Completed 24, Recruiting 3, Active not recruiting 2, Not yet recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 14Completed 2, Not yet recruiting 1, Recruiting 1
Phase 31Completed 1

Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
Sintilimab - HIV, AIDS
Phase 1 / Phase 2Not yet recruitingShanghai Public Health Clinical Center502026-05-012026-05-12
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
Recombinant human interleukin (IL) 7-hyFc - Idiopathic CD4 Lymphopenia
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)602024-11-062026-10-19
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event
Phase 2UnknownMahidol University1602023-07-052024-04-05
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Busulfan test dose, Fludarabine, Busulfan - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative
Phase 2RecruitingNational Cancer Institute (NCI)662020-09-222026-11-12
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
ATL-RIC, mRIC, allo HCT - Peripheral T-cell Lymphomas, Lymphoproliferative Disorders
Phase 2Active not recruitingNational Cancer Institute (NCI)1182019-04-182026-11-09
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative
Phase 2Active not recruitingNational Cancer Institute (NCI)712018-09-042026-03-17
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
CD45RA-depleted peripheral blood mononuclear cells - Leukemia, Lymphoma
Phase 2 / Phase 3CompletedFederal Research Institute of Pediatric Hematology, Oncology and Immunology1502016-10-012023-03-16
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Immunosuppression Only Conditioning -Closed with amendment L, Reduced Intensity Conditioning, Myeloablative Conditioning-Closed with amendment L - Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency
Phase 2RecruitingNational Cancer Institute (NCI)3542015-11-192026-11-05
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation
CD45RA-depleted peripheral blood mononuclear cells - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute
Phase 1 / Phase 2CompletedFederal Research Institute of Pediatric Hematology, Oncology and Immunology302014-08-012016-04-22
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
Nelfinavir mesylate - Sarcoma, Kaposi, HIV Infections
Phase 2CompletedAgouron Pharmaceuticals202005-06-24
Dexamethasone in Cryptococcal Meningitis
Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362021-10-28
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
Nelfinavir mesylate - Mycobacterium Avium-Intracellulare Infection, HIV Infections
Phase 2CompletedAgouron Pharmaceuticals2005-06-24
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Atovaquone, Sulfamethoxazole-Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3002011-03-01
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
Foscarnet sodium - Cytomegalovirus Retinitis, HIV Infections
Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2021-11-04
A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients
Sitamaquine - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)452021-10-28
A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
Foscarnet sodium - Cytomegalovirus Retinitis, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1562021-11-03
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
L-743,872 - Candidiasis, Oral, HIV Infections
Phase 2TerminatedMerck Sharp & Dohme LLC702005-06-24
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
Zidovudine, Acyclovir - HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)4002021-11-04
A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)
Sevirumab - Cytomegalovirus Retinitis, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3002012-10-25
A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
Nitazoxanide - Cryptosporidiosis, HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)602021-11-01

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

AIDS-Related Opportunistic Infections (24)  ·  HIV Infections (24)  ·  Acquired Immunodeficiency Syndrome (13)  ·  Cytomegalovirus Retinitis (6)  ·  Autoimmune Diseases (4)  ·  Cytomegalovirus Infections (4)  ·  Immune System Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (4)  ·  Common Variable Immunodeficiency (3)  ·  Mycobacterium avium-intracellulare Infection (3)  ·  Retinitis (3)  ·  T cell immunodeficiency primary (3)  ·  Candidiasis, Oral (2)

Broader conditions

Infections (33)  ·  Immunologic Deficiency Syndromes (29)  ·  Immune System Diseases (28)  ·  Blood-Borne Infections (25)  ·  Communicable Diseases (25)  ·  Genital Diseases (25)  ·  Lentivirus Infections (25)  ·  RNA Virus Infections (25)  ·  Retroviridae Infections (25)  ·  Sexually Transmitted Diseases (25)  ·  Sexually Transmitted Diseases, Viral (25)  ·  Urogenital Diseases (25)  ·  Virus Diseases (25)  ·  Slow Virus Diseases (14)

Interventions

Foscarnet (3)  ·  Nelfinavir (3)  ·  Busulfan (2)  ·  Clarithromycin (2)  ·  Cyclophosphamide (2)  ·  Fluconazole (2)  ·  Ganciclovir (2)  ·  Mycophenolic Acid (2)  ·  Tacrolimus (2)  ·  Zidovudine (2)  ·  nitazoxanide (2)  ·  sevirumab (2)  ·  8-aminoquinoline (1)  ·  Absorptiometry, Photon (1)  ·  Acyclovir (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (16)  ·  National Cancer Institute (NCI) (4)  ·  Agouron Pharmaceuticals (3)  ·  Anderson Clinical Research (2)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (2)  ·  Ionis Pharmaceuticals, Inc. (1)  ·  Mahidol University (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Schering-Plough (1)  ·  Shanghai Public Health Clinical Center (1)  ·  SmithKline Beecham (1)

Countries

United States (26)  ·  Thailand (3)  ·  Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Puerto Rico (2)  ·  Russia (2)  ·  South Africa (2)  ·  Argentina (1)  ·  Chile (1)  ·  China (1)  ·  Dominican Republic (1)  ·  Ethiopia (1)  ·  Guatemala (1)

Top investigators

Dimana Dimitrova, M.D. (3)  ·  MA Jacobson (2)  ·  Andrea Lisco, M.D. (1)  ·  Black J (1)  ·  Borucki M (1)  ·  C Crumpacker (1)  ·  CS Crumpacker (1)  ·  Chaisson R (1)  ·  Collier AC (1)  ·  Corey L (1)  ·  D Richman (1)  ·  Dohn M (1)  ·  Fichtenbaum C (1)  ·  Frame P (1)  ·  Gnann J (1)

Results publications

PMID 15498605, PMID 41370196